US 3D Medical Printing Market Overview
The 3D Medical Printing Market Size was valued at USD 6.03 billion in 2022 and is projected to grow from USD 7.51 Billion in 2024 to USD 26.68 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 16.59% during the forecast period (2024 - 2032). One of the main market drivers of growth in the 3D medical printing market is the major players in the industry's quick technological advancements.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
3D Medical Printing Market Trends
- Rising incidence of osteoarthritis and related musculoskeletal disorders is driving the market growth
The increasing incidence of osteoarthritis and related musculoskeletal disorders is one of the main drivers driving the market for US 3D medical printing. Patients with osteoarthritis experience pain, stiffness, and a loss of joint function as a result of the disease, which damages the cartilage in the joints and the tissues around them. Surgeons can access important information that may not be accessible on a 2-dimensional scan by employing 3D printing technology to replicate a patient's joint. Osteoarthritis is more common as people get older. For instance, a survey from the U.S. National Library of Medicine predicts that by 2040, 78 million (or 26%) of adult Americans who are 18 years of age and older would have a formal diagnosis of arthritis. Therefore, encouraging the adoption of medical gadgets that are 3D printed and facilitating industry growth.
For those who are in need, organ transplantation is an essential and frequently life-saving action. It is now feasible to finish this process without depending on human donors because to developments in medical technology. The number of organ transplants performed worldwide in 2021 was 144.302, as reported by the Global Observatory on Donation and Transplantation. Organ transplant waiting lists included 104,234 men, women, and children as of 2022.
Organ transplant recipients in the United States lose up to 17 lives every day as a result of the lack of resources and information surrounding organ donation. This yearly death toll exceeds 6,000. Furthermore, the lack of organ donors and the high rate of organ failure is restricting the growing need for transplantable organs; nevertheless, medical 3D printing holds promise to address these issues. The prevalence of organ failures has increased due to factors including heavy tobacco usage, sedentary lifestyles, accidents, and chronic diseases, which has further boosted the demand for organ transplantation. Thus, driving the 3D medical printing market revenue.
3D Medical Printing Market Segment Insights:
3D Medical Printing Component Insights
The US 3D Medical Printing market segmentation, based on component includes Equipment (3D Printers, 3D Bioprinters), Metals and Metal Alloys, Biomaterials, Ceramics, Materials (Plastics (Thermoplastics, Photopolymers), Paper, Wax, Other Materials) and Services & Software. The equipment segment dominated the market mostly. Due to its portability and ability to be transported to remote locations, the sophisticated technology utilized in the healthcare industry has expanded the scope of services available. To ensure that the operation proceeds without a hitch and that the intended outcomes are obtained, it is imperative that the healthcare industry provides faultless services.
3D Medical Printing Application Insights
The US 3D Medical Printing market segmentation, based on application includes Surgical Instruments (Surgical Fasteners, Scalpels, Retractors), Surgical Guides (Dental Guides, Craniomaxillofacial Guides, Orthopedic Guides, Spinal Guides), Standard Prosthetics & Implants, Custom Prosthetics & Implants (Orthopedic Implants, Craniomaxillofacial Implants, Dental Prosthetics & Implants,), Tissue-engineered Products (Bone & Cartilage Scaffolds, Ligament & Tendon Scaffolds), Hearing Aids, Wearable Medical Devices, and Other Applications. The wearable medical devices segment dominated the market mostly because of the abundance of patients, the relaxation of rules governing 3D printers, the rise in the use of this technology in hospitals and dentistry offices, and customizations. During the course of the forecast period, these factors are anticipated to accelerate market growth.
3D Medical Printing Technology Insights
The US 3D Medical Printing market segmentation, based on technology includes Laser Beam Melting (Direct Metal Laser Sintering, Selective Laser Sintering, Selective Laser Melting, LaserCUSING), Droplet Deposition/Extrusion-based Technologies (Fused Deposition Modeling, Multiphase Jet Solidification, Low-temperature Deposition Manufacturing, Microextrusion Bioprinting), Photopolymerization (Digital Light Processing, Stereolithography, Two-photon Polymerization, PolyJet 3D Printing), Electron Beam Melting, Three-dimensional Printing/Adhesion Bonding/Binder Jetting, and Other Technologies.
The Droplet Deposition/Extrusion-based Technologies segment dominated the market mostly. The ability of 3D printing technology to withstand chemicals has become one of its main draws for prospective customers. Due to their ability to tolerate extremely high temperatures, these materials are found in many highly durable items on the market. The market's size has increased significantly due to the growing demand for new technology among consumers, and this trend is anticipated to continue in the coming years.
3D Medical Printing End User Insights
The US 3D Medical Printing market segmentation, based on end user, includes Hospitals & Surgical Centers, Dental & Orthopedic Clinics, Pharma-Biotech & Medical Device Companies, Academic Institutions & Research Laboratories, and Clinical Research Organizations. The hospitals & surgical centers category generated the most income. The market for 3D medical printing is expanding due to a number of factors, such as increased government and private sector investments in 3D printing technology and a rise in university-business partnerships. These elements have created opportunities for 3D printing's expansion in the healthcare industry.
Figure 1: US 3D Medical Printing Market, by End User, 2024 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
3D Medical Printing Regional Insights
The US 3D medical printing market area will grow at a significant rate. The market has grown significantly as a result of the government's acceleration of improvements in the healthcare industry. Growing consumer awareness of the options accessible to them has also contributed to the market's sustained significant revenue growth. One of the main drivers of growth for the 3D medical printing market is the enormous volume of surgical procedures performed in this area. Furthermore, factors like as significant product releases, a high concentration of manufacturers or market players, collaborations and acquisitions among big companies, and an increase in research activity in the US are some of the ones propelling the 3D medical printing market's expansion.
3D Medical Printing Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the 3D medical printing market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, 3D medical printing industry must offer cost-effective items.
Key Companies in the 3D medical printing market include
- Stratasys Ltd. (Israel)
- EnvisionTEC (US)
- 3D Systems, Inc. (US)
- EOS (US)
- Renishaw plc (UK)
- GE additive (US)
- Desktop Metal, Inc (US)
- CELLINK (Sweden)
- Formalabs (US)
- Materialise (Belgium)
- 3T Additive Manufacturing Ltd. (US)
- GENERAL ELECTRIC COMPANY (US)
- Carbon, Inc. (US)
- Prodways Group (France)
- SLM Solutions (Germany)
- Organovo Holdings Inc. (US)
- FIT AG (Germany)
- Wacker Chemie AG (Germany)
- Denstply Sirona (USA)
- DWS Systems SRL (Italy)
- Roland DG (Japan)
- HP,Inc (USA)
- regenHU (Switzerland)
- FluicelI (Sweden)
- Proto Labs(US)
- GESIM( Germany)
- Triastek (China)
- Inventia (Australia)
- FabRx (UK)
- Apprecia Pharmaceuticals (US)
3D Medical Printing Market Segmentation
3D Medical Printing Component Outlook
- Equipment
- 3D Printers
- 3D Bioprinters
- Materials
- Plastics
- Thermoplastics
- Photopolymers
- Metals and Metal Alloys
- Biomaterials
- Ceramics
- Paper
- Wax
- Other Materials
- Services & Software
3D Medical Printing Application Outlook
- Surgical Guides
- Dental Guides
- Craniomaxillofacial Guides
- Orthopedic Guides
- Spinal Guides
- Surgical Instruments
- Surgical Fasteners
- Scalpels
- Retractors
- Standard Prosthetics & Implants
- Custom Prosthetics & Implants
- Orthopedic Implants
- Dental Prosthetics & Implants
- Craniomaxillofacial Implants
- Tissue-engineered Products
- Bone & Cartilage Scaffolds
- Ligament & Tendon Scaffolds
- Hearing Aids
- Wearable Medical Devices
- Other Applications
3D Medical Printing Technology Outlook
- Laser Beam Melting
- Direct Metal Laser Sintering
- Selective Laser Sintering
- Selective Laser Melting
- LaserCUSING
- Photopolymerization
- Digital Light Processing
- Stereolithography
- Two-photon Polymerization
- PolyJet 3D Printing
- Droplet Deposition/Extrusion-based Technologies
- Fused Deposition Modeling
- Multiphase Jet Solidification
- Low-temperature Deposition Manufacturing
- Microextrusion Bioprinting
- Electron Beam Melting
- Three-dimensional Printing/Adhesion Bonding/Binder Jetting
- Other Technologies
3D Medical Printing End User Outlook
- Hospitals & Surgical Centers
- Dental & Orthopedic Clinics
- Academic Institutions & Research Laboratories
- Pharma-Biotech & Medical Device Companies
- Clinical Research Organizations
Report Attribute/Metric |
Details |
Market Size 2022 |
6.03 |
Market Size 2024 |
7.51 |
Market Size 2032 |
26.68 |
Compound Annual Growth Rate (CAGR) |
16.59 (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2018- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Component, Application, Technology, End User, and Region |
Countries Covered |
US |
Key Companies Profiled |
Stratasys Ltd. (Israel), EnvisionTEC (US), 3D Systems, Inc. (US), EOS (US), Renishaw plc (UK), GE additive (US), Desktop Metal, Inc (US), CELLINK (Sweden), Formalabs (US), Materialise (Belgium), 3T Additive Manufacturing Ltd. (US), GENERAL ELECTRIC COMPANY (US), Carbon, Inc. (US), Prodways Group (France), SLM Solutions (Germany), Organovo Holdings Inc. (US), FIT AG (Germany), Wacker Chemie AG (Germany), Denstply Sirona (USA), DWS Systems SRL (Italy), Roland DG (Japan), HP,Inc (USA), regenHU (Switzerland), FluicelI (Sweden), Proto Labs (US), GESIM (Germany), Triastek (China), Inventia (Australia), FabRx (UK) and Apprecia Pharmaceuticals (US) |
Key Market Opportunities |
Technological Developments Improving Application |
Key Market Dynamics |
Growing Demand as a Result of Growing Medical Applications · Growing Trend in Personalized 3D Printing |
US 3D Medical Printing Market Highlights:
Frequently Asked Questions (FAQ) :
The US 3D Medical Printing market size was valued at USD 6.03 Billion in 2022.
The market is projected to grow at a CAGR of 16.59 during the forecast period, 2024-2032.
The key players in the market are Stratasys Ltd. (Israel), EnvisionTEC (US), 3D Systems, Inc. (US), EOS (US), Renishaw plc (UK), GE additive (US), Desktop Metal, Inc (US), CELLINK (Sweden), Formalabs (US), Materialise (Belgium), 3T Additive Manufacturing Ltd. (US), GENERAL ELECTRIC COMPANY (US), Carbon, Inc. (US), Prodways Group (France), SLM Solutions (Germany), Organovo Holdings Inc. (US), FIT AG (Germany), Wacker Chemie AG (Germany), Denstply Sirona (USA), DWS Systems SRL (Italy), Roland DG (Japan), HP,Inc (USA), regenHU (Switzerland), FluicelI (Sweden), Proto Labs(US), GESIM( Germany), Triastek (China), Inventia (Australia), FabRx (UK) and Apprecia Pharmaceuticals (US).
The Wearable Medical Devices category dominated the market in 2022.
The Hospitals & Surgical Centers category had the largest share in the market.